Factor VIIa

凝血因子 VIIa 是凝血因子 VII 的活性形式,在凝血过程中发挥着重要作用。凝血因子 VIIa 能与组织因子结合形成复合物,激活凝血因子 IX 以及凝血因子 X,促使血液凝固。此外,在血管损伤时,凝血因子 VIIa 能快速启动凝血过程,在损伤处形成纤维蛋白凝块,实现生理性止血。凝血因子 VIIa 与疾病密切相关,其缺乏会引发过度出血,水平过高会增加血栓性疾病的风险。由于其具有促进凝血的功能,因此凝血因子 VIIa 也被用作治疗血友病、血小板减少症等多种出血性疾病的止血剂[1][2]。

Factor VIIa is the active form of factor VII and plays an important role in the process of blood coagulation. Factor VIIa can combine with tissue factor to form a complex, activating factor IX and factor X, thereby promoting blood coagulation. In addition, when there is vascular injury, factor VIIa can quickly initiate the blood coagulation process, forming a fibrin clot at the site of injury to achieve physiological hemostasis. Factor VIIa is closely related to diseases. Its deficiency can lead to excessive bleeding, and an excessively high level of it can increase the risk of thrombotic diseases. Factor VIIa, due to its well-known ability to promote coagulation, is also used as a hemostatic agent in the treatment of several hyper bleeding disorders like hemophilia, thrombocytopenia etc[1][2].

By Effects: Inhibitor (4)
共 4种化合物
Cat. No.
Product Name
CAS No.
Effect
Purity
Chemical Structure
ARC19499
BAX499

ARC19499 是一种核酸适配体,能特异性结合组织因子通路抑制剂(TFPI),阻断 TFPI 对 factor Xa 和 TF/factor VIIa 复合物的抑制作用,从而纠正血友病 A 和 B 血浆中的凝血酶生成并恢复凝血。

1350667-54-7
Inhibitor
ARC19499
ARC19499 sodium
BAX499 sodium

ARC19499 sodium 是一种核酸适配体,与组织因子通路抑制剂(TFPI)特异性结合,阻断 TFPI 对 factor Xa 和 TF/factor VIIa 复合物的抑制作用,从而纠正血友病 A 和 B 血浆中的凝血酶生成并恢复凝血。

Inhibitor
99.40%
ARC19499 sodium
ARC19499 sodium scrambled negative control

ARC19499 sodium scrambled negative control 是 ARC19499 sodium 的乱序阴性对照。

Inhibitor
ARC19499 sodium scrambled negative control
PCI-27483

PCI-27483 是一种 FVIIa/组织因子抑制剂,具有抗肿瘤活性。

871266-63-6
Inhibitor
99.10%
PCI-27483

开始您的科研之旅

20,0000+ 种高纯度分子化合物,专业靶点数据库,全程技术支持
让每一个实验数据都有坚实的分子基础